• Medientyp: E-Artikel
  • Titel: Prognostic impact of coronary lesions and its revascularization in a 5‐year follow‐up after the TAVI procedure
  • Beteiligte: Vázquez, Domingo José López; López, Guillermo Aldama; Guzmán, Martin Quintas; Cancelo, Ariana Varela; Leal, Fernando Rebollal; Rios, Xacobe Flores; Esteban, Pablo Piñón; Fernandez, Jorge Salgado; Santos, Ramón Calviño; Rodriguez, José Manuel Vázquez
  • Erschienen: Wiley, 2023
  • Erschienen in: Catheterization and Cardiovascular Interventions
  • Sprache: Englisch
  • DOI: 10.1002/ccd.30767
  • ISSN: 1522-1946; 1522-726X
  • Schlagwörter: Cardiology and Cardiovascular Medicine ; Radiology, Nuclear Medicine and imaging ; General Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Coronary artery disease (CAD) is a common finding in patients undergoing transcatheter aortic valve implantation (TAVI). However, its prognostic significance and its management remains controversial.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>This study sought to determine whether the presence of CAD, its complexity, and angiography‐guided percutaneous coronary intervention (PCI) are associated with outcomes after TAVI.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>All patients undergoing TAVI at a tertiary referral center between 2008 and 2018 were included in a prospective observational study. Baseline SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score (SS) and a residual SS after PCI were calculated. The endpoints on the 5 year follow‐up were all‐cause mortality and a composite of mayor cardiovascular adverse events (MACE).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In 379 patients, the presence of CAD and its complexity were not significantly associated with worse 5‐year survival after TAVI, with a mortality for SS0 of 45%; for SS 1–22 of 36.5% (HR 0.77; 95% CI 0.53–1.11, <jats:italic>p</jats:italic> = 0.15) and for SS &gt; 22 of 42.1% (HR 1.24; 95% CI 0.59–2.63, <jats:italic>p</jats:italic> = 0.57). Regarding the combined event of MACE, there were also no statistically significant differences between patients with CAD and without CAD (56.8% in patients without CAD and 54.9% in patients with CAD; HR 1.06; 95% CI 0.79–1.43, <jats:italic>p</jats:italic> = 0.7). Angiography‐guided PCI or completeness of revascularization was not associated with different outcomes.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>In the present analysis, neither the presence nor the extent of CAD, nor the degree of revascularization, was associated with a prognostic impact in patients undergoing TAVI at 5‐year follow‐up.</jats:p></jats:sec>